{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:15:56Z","timestamp":1791274556324,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.ejphar.2009.01.049","type":"journal-article","created":{"date-parts":[[2009,2,11]],"date-time":"2009-02-11T12:27:33Z","timestamp":1234355253000},"page":"114-120","source":"Crossref","is-referenced-by-count":28,"title":["The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat"],"prefix":"10.1016","volume":"607","author":[{"given":"Elizabeth L.","family":"van der Kam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"De Vry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Tzschentke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.01.049_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-005-0092-6","article-title":"Cortical glutamate\u2013dopamine interaction and ketamine-induced psychotic symptoms in man","volume":"182","author":"Aalto","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2009.01.049_bib2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1460-9568.2004.03609.x","article-title":"Metabotropic glutamate receptor 5 localized in the limbic forebrain is critical for the devlopment of morphine-induced rewarding effect in mice","volume":"20","author":"Aoki","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2009.01.049_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/sj.npp.1300845","article-title":"Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine-seeking","volume":"31","author":"Backstrom","year":"2006","journal-title":"NeuroPsychopharmacology"},{"key":"10.1016\/j.ejphar.2009.01.049_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2006.08.071","article-title":"mGlu5 receptors are involved in the discriminative stimulus effects of self-administered ethanol in rats","volume":"551","author":"Besheer","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.01.049_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2005.06.007","article-title":"Metabotropic glutamate receptor (mGlu5 receptor) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats","volume":"49","author":"Bespalov","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.01.049_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0741-8329(93)90087-5","article-title":"Species difference in sensitivity to ethanol's hedonic effects","volume":"10","author":"Cunningham","year":"1993","journal-title":"Alcohol."},{"key":"10.1016\/j.ejphar.2009.01.049_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0091-3057(02)00734-7","article-title":"Injection timing determines whether intragastric ethanol produces conditioned place preference or aversion in mice","volume":"72","author":"Cunningham","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2009.01.049_bib8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1037\/0735-7044.120.5.1115","article-title":"Spatial location is critical for conditioning place preference with visual but not tactile stimuli","volume":"120","author":"Cunningham","year":"2006","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2009.01.049_bib9","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0028-3908(99)00082-9","article-title":"2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist","volume":"38","author":"Gasparini","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.01.049_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0028-3908(03)00209-0","article-title":"Neuroprotective action of MPEP, a selective mGlu5 receptor antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats","volume":"45","author":"Golembiowska","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.01.049_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/13556210500223272","article-title":"Effects of MPEP on expression of food-, MDMA- or amphetamine-conditioned place preference in rats","volume":"10","author":"Herzig","year":"2005","journal-title":"Addict. Biol."},{"key":"10.1016\/j.ejphar.2009.01.049_bib12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.neuropharm.2004.07.037","article-title":"Effects of MPEP on locomotion, sensitzation and conditioned rewards induced by cocaine or morphine","volume":"47","author":"Herzig","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.01.049_bib13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.npp.1300417","article-title":"Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release","volume":"29","author":"Homayoun","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2009.01.049_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00213-004-2069-2","article-title":"Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing barain reward function in rats","volume":"179","author":"Kenny","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2009.01.049_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tips.2004.03.009","article-title":"The ups and downs of addiction: role of metabotropic glutamate receptors","volume":"25","author":"Kenny","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2009.01.049_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00726-001-0130-6","article-title":"In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article","volume":"23","author":"Kuhn","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejphar.2009.01.049_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00213-004-2021-5","article-title":"Nicotine induced conditioned place preference over a large range of doses in rats","volume":"178","author":"Le Foll","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2009.01.049_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1527-3458.2006.00149.x","article-title":"Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP","volume":"12","author":"Lea","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejphar.2009.01.049_bib19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1124\/jpet.104.078733","article-title":"Attenuation of behavioural effects of cocaine by the metabotrobic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison wirh dizocilpine","volume":"312","author":"Lee","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.01.049_bib20","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1038\/sj.npp.1300284","article-title":"Effects of cocaine in rats exposed to heroin","volume":"28","author":"Leri","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2009.01.049_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2006.10.011","article-title":"Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2\/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats","volume":"554","author":"Liechti","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.01.049_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2005.10.038","article-title":"The serotonin\/noradrenaline reuptake inhibitor venlafaxine attenuates acquisition, but not maintenance, of intravenous self-administration of heroin in rats","volume":"528","author":"Magalas","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.01.049_bib23","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2009.01.049_bib24","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.bjp.0703715","article-title":"Selective mGlu5 receptor antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism","volume":"131","author":"O'Leary","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.01.049_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1124\/mol.104.003319","article-title":"The mGlu5 receptor antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism","volume":"67","author":"Olive","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.01.049_bib26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00213-004-2070-9","article-title":"The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats","volume":"179","author":"Paterson","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2009.01.049_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-003-1432-z","article-title":"The mGlu5 receptor antagonist MPEP decreased nicotine self-administration in rats and mice","volume":"167","author":"Paterson","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2009.01.049_bib28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0028-3908(02)00309-X","article-title":"Morphine conditioned reward is inhibited by MPEP, the mGlu5 receptor antagonist","volume":"43","author":"Popik","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.01.049_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0091-3057(00)00273-2","article-title":"Sensitization to cocaine's reinforcing effects produced by various cocaine pretreatment regimens in rats","volume":"66","author":"Schenk","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2009.01.049_bib30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00213-005-2175-9","article-title":"The mGlu5 receptor antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats","volume":"179","author":"Schroeder","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2009.01.049_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/000992280504400702","article-title":"Adolescent abuse of dextromethorphan","volume":"44","author":"Schwartz","year":"2005","journal-title":"Clin. Pediatr. (Phila)"},{"key":"10.1016\/j.ejphar.2009.01.049_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s002130100748","article-title":"Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats","volume":"156","author":"Shalev","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2009.01.049_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.54.1.1","article-title":"Neurobiology of relapse to heroin and cocaine seeking: a review","volume":"54","author":"Shalev","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2009.01.049_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-979537","article-title":"Adaptation of the N-methyl-d-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression","volume":"29","author":"Skolnick","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejphar.2009.01.049_bib35","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjp.0703923","article-title":"Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist","volume":"132","author":"Tatarczynska","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.01.049_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00213-003-1626-4","article-title":"Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerations","volume":"172","author":"Tzschentke","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2009.01.049_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(02)00571-2","article-title":"Lack of sensitization during place conditioning in rats is consistent with the low abuse potential of tramadol","volume":"329","author":"Tzschentke","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.ejphar.2009.01.049_bib38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/FBP.0b013e3282f18d58","article-title":"Effect of 2-methyl-6-(phenylethynyl)pyridine on intravenous self-administration of ketamine and heroin in the rat","volume":"18","author":"Van der Kam","year":"2007","journal-title":"Beh. Pharmacology"},{"key":"10.1016\/j.ejphar.2009.01.049_bib39","unstructured":"Van der Kam, E.L., De Vry, J., Tzschentke, T.M., in press. 2-Methyl-6(phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat. Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.01.049_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-6147(97)01164-4","article-title":"Dizocilpine (MK801): use or abuse?","volume":"19","author":"Vanderschuren","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2009.01.049_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1523\/JNEUROSCI.16-01-00373.1996","article-title":"NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine","volume":"16","author":"Verma","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2009.01.049_bib42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.neubiorev.2003.11.001","article-title":"Sensitization of midbrain dopaminergic neuron reactivity and the self-administration of psychomotor stimulant drugs","volume":"27","author":"Vezina","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2009.01.049_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00023210-200620030-00003","article-title":"Ketamine: from medicine to misuse","volume":"20","author":"Wolff","year":"2006","journal-title":"CNS Drugs"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T23:32:15Z","timestamp":1558135935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299909001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":43,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0014299909001174"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.01.049","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}